SCHEMBL4853352

SCHEMBL4853352

COc1ccc(C=CC(=O)c2cc(-c3cc(C)cc(C)c3)ccc2OCCN(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.51
MAPT P10636 4/20 0.47
TNFRSF1A P19438 1/20 0.47
FLT3 P36888 1/20 0.47
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
MEN1 O00255 2/20 0.45
MAPK1 P28482 2/20 0.45
KMT2A Q03164 2/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
USP2 O75604 1/20 0.45
TLR9 Q9NR96 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854085 1.00 ABCG2 (0.51) ABCG2MAPTTNFRSF1AFLT3LMNA
SCHEMBL4852212 0.90 BCHE (0.44) LMNABCHEACHEMAOAMAOB
SCHEMBL4852224 0.90 SYK (0.44) ABCG2BCHEACHEMAOB
SCHEMBL4853723 0.90 BCHE (0.44) LMNABCHEACHEMAOAMAOB
SCHEMBL4849963 0.90 SYK (0.44) ABCG2BCHEACHEMAOB
SCHEMBL4856235 0.89 MAOA (0.46) BCHEACHEMAOAMAOB
SCHEMBL4849917 0.89 SYK (0.45) ABCG2MAPTLMNASMN1; SMN2BCHE
SCHEMBL6141442 0.89 MAOA (0.46) BCHEACHEMAOAMAOB
SCHEMBL4852436 0.89 BCHE (0.54) ABCG2MAPTTNFRSF1ABCHEACHE
SCHEMBL4849159 0.89 BCHE (0.54) ABCG2MAPTTNFRSF1ABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed